soul trial oral semaglutide cardiovascular outcomes nejm 2025 results and in Patients with Type 2 Diabetes soul trial oral semaglutide cardiovascular

In addition to the typical ingredients, this non-carbonated drink contained inositol, a kind of sugar found in the brain, and taurine

GUO: Marta says this was all highly unusual

You feel less hungry, so you make better choices when you eat

Trial registry Clinicaltrials.gov, Identifying number: NCT01720446, Date of registration: October 29, 2012 Similar content being viewed by others Background Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in people with type 2 diabetes (T2D) [1, 2], and diabetes itself confers a substantial independent risk of coronary heart disease, stroke, and death from other vascular causes [3]